Rationale for anti-IL-17A treatment in bullous pemphigoid

被引：0
|
作者：
Chakievska, L. [1 ]
Holtsche, M. M. [2 ]
Hammers, C. M. [2 ]
Goletz, S. [1 ]
Zillikens, D. [2 ]
Schultze, F. S. [1 ]
Hoelscher, C. [3 ]
Schmidt, E. [1 ,2 ]
机构：
[1] Univ Lubeck, Lubeck Inst Expt Dermatol, Lubeck, Germany
[2] Univ Lubeck, Dept Dermatol, Lubeck, Germany
[3] Res Ctr Borstel, Prior Area Infect, Div Infect Immunol, Borstel, Germany
来源：
EXPERIMENTAL DERMATOLOGY | 2018年 / 27卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P075 (OP01
引用
收藏
页码：E31 / E32
页数：2
相关论文
共 50 条
  • [1] Secukinumab: The Anti-IL-17A Biologic for the Treatment of Psoriasis
    Fargnoli, Maria Concetta
    CASE REPORTS IN DERMATOLOGY, 2019, 11 : 1 - 3
  • [2] Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis
    Frieder, Jillian
    Kivelevitch, Dario
    Menter, Alan
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2018, 9 (01) : 5 - 21
  • [3] IXEKIZUMAB Anti-IL-17A monoclonal antibody Treatment of psoriasis
    Haddley, K.
    DRUGS OF THE FUTURE, 2015, 40 (07) : 421 - 431
  • [4] Successful Treatment of Acrodermatitis Continua of Hallopeau with an Anti-IL-17A Agent
    Inoue, Sae
    Watanabe, Rei
    Ishitsuka, Yosuke
    Nakamura, Yoshiyuki
    Fujisawa, Yasuhiro
    Okiyama, Naoko
    Fujimoto, Manabu
    INDIAN JOURNAL OF DERMATOLOGY, 2021, 66 (02)
  • [5] Ixekizumab: an anti-IL-17A monoclonal antibody for the treatment of psoriatic arthritis
    Toussirot, Eric
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (01) : 101 - 107
  • [6] Anti-IL-17 monoclonal antibodies and bullous pemphigoid: treatment or causal agents? A case series and review of the literature
    Lugli, Anna Paola
    Caldarola, Giacomo
    Falco, Gennaro Marco
    Montedoro, Costanza
    Mulas, Camilla
    De Simone, Clara
    DRUGS IN CONTEXT, 2024, 13
  • [7] IL-17 Expression in Dermatitis Herpetiformis and Bullous Pemphigoid
    Zebrowska, Agnieszka
    Wagrowska-Danilewicz, Malgorzata
    Danilewicz, Marian
    Stasikowska-Kanicka, Olga
    Cynkier, Anna
    Sysa-Jedrzejowska, Anna
    Waszczykowska, Elzbieta
    MEDIATORS OF INFLAMMATION, 2013, 2013
  • [8] IL-17 expression in dermatitis herpetiformis and bullous pemphigoid
    Zebrowska, A.
    Wagrowska-Danilewicz, M.
    Danilewicz, M.
    Stasikowska-Kanicka, O.
    Cynkier, A.
    Sysa-Jedrzejowska, A.
    Waszczykowska, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S17 - S17
  • [9] IL-17A is a key regulator in experimental bullous pemphigoid
    Chakievska, L.
    Schultze, F.
    Goletz, S.
    Zillikens, D.
    Hoelscher, C.
    Schmidt, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S248 - S248
  • [10] DISTINCT AND OVERLAPPING ACTIVITIES OF IL-17A AND TNF ON THE EXPRESSION OF PROINFLAMMATORY CYTOKINES AND MMPS IN PSORIATIC ARTHRITIS: RATIONALE FOR ANTI-IL-17A/ANTI-TNFALPHA COMBINATION THERAPY?
    Xu, X.
    Davelaar, N.
    Otten-Mus, A-M
    Asmawidjaja, P.
    Hazes, J.
    Baeten, D.
    Vis, M.
    Bisoendial, R.
    Lubberts, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : A53 - A53
12345